Results 271 to 280 of about 81,306 (284)

Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis

Annals of Oncology, 2013
F Wen
exaly  

Oxaliplatin

Reactions Weekly, 2013
openaire   +2 more sources

Oxaliplatin

Reactions Weekly, 2010
openaire   +2 more sources

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial

Annals of Oncology, 2019
M A Lee, S Y Oh, J S Jang
exaly  

Oxaliplatin

Reactions Weekly, 2017
openaire   +1 more source

Cucurbit[7]uril Containers for Targeted Delivery of Oxaliplatin to Cancer Cells†

Angewandte Chemie - International Edition, 2013
Volker Briken, Liping Cao, Lyle D Isaacs
exaly  

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology, 2016
Stephen Ackland, Ralf-Dieter Hofheinz, Gunnar Folprecht   +2 more
exaly  

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

Annals of Oncology, 2012
Jordi Bruna, Haralabos Kalofonos
exaly  

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study

Annals of Oncology, 2003
S R Alberts, D F Moore, R M Goldberg
exaly  

Oxaliplatin

Reactions Weekly, 2006
openaire   +1 more source